BFEC
NRC icon

Benjamin F. Edwards & Company’s NRC Health Common Stock NRC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$64K Buy
2,783
+1,650
+146% +$50.9K ﹤0.01% 1267
2024
Q1 		$45K Buy
1,133
+1,015
+860% +$40.1K ﹤0.01% 1330
2023
Q4 		$5K Sell
118
-77
-39% -$3.22K ﹤0.01% 1857
2023
Q3 		$9K Sell
195
-17
-8% -$742 ﹤0.01% 1424
2023
Q2 		$9K Sell
212
-65
-23% -$2.86K ﹤0.01% 1430
2023
Q1 		$12K Sell
277
-121
-30% -$5.34K ﹤0.01% 1372
2022
Q4 		$15K Sell
398
-60
-13% -$2.32K ﹤0.01% 1342
2022
Q3 		$18K Hold
458
– – ﹤0.01% 1283
2022
Q2 		$18K Sell
458
-37
-7% -$1.34K ﹤0.01% 1260
2022
Q1 		$20K Sell
495
-69
-12% -$2.7K ﹤0.01% 1232
2021
Q4 		$23K Sell
564
-341
-38% -$14.8K ﹤0.01% 1210
2021
Q3 		$38K Buy
+905
New +$45.6K ﹤0.01% 1089
2020
Q2 		– Sell
-403
Closed -$18K – 1756
2020
Q1 		$18K Buy
403
+215
+114% +$12.9K ﹤0.01% 1107
2019
Q4 		$12K Buy
+188
New +$11.5K ﹤0.01% 1381

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Benjamin F. Edwards & Company's NRC Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its NRC Health Common Stock (NRC) stake by 146% in Q2 2024, buying an estimated $50.9K and bringing the position to 2,783 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.

Benjamin F. Edwards & Company first reported a position in NRC in Q4 2019 and has held it in 14 quarters since. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Benjamin F. Edwards & Company held 2,783 shares of NRC Health Common Stock worth $64K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 1,650 NRC Health Common Stock shares in Q2 2024, an estimated $50.9K.
  • NRC Health Common Stock made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1267 holding.
  • Benjamin F. Edwards & Company first reported a position in NRC Health Common Stock in Q4 2019 and has held it in 14 quarters since.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.